Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lev T. Perelman, Ph.D.

Title
Institution
Department
Address
Phone
Other Positions
Title
Institution
Department

Biography
1997
Keynote Speaker, Gordon Research Conference
2000
AIP Top Ten Accomplishments in Biophysics for the Decade
2012
General Chair-Elect, OSA Biomedical Optics and 3-D Imaging Congress
2012
Emerging Frontiers in Research and Innovation Award
2014
Plenary Speaker, OSA Biomedical Optics and 3-D Imaging Congress
2017
BiOS Hot Topics Plenary Speaker

Overview
Three main research programs at the Center for Advanced Biomedical Imaging and Photonics are: 1) in vivo optical detection of preinvasive cancer; 2) studying sub-cellular morphology with confocal light absorption and scattering spectroscopic microscopy and 3) development of optical spectroscopic technique for noninvasive prenatal diagnosis. The Center develops and uses a variety of different tools and platforms for in vivo optical biomedical imaging.

In Vivo Optical Detection of Preinvasive Cancer

The purpose of this program is to develop an optical system which can perform rapid optical scanning and multispectral imaging of the entire epithelial surface of various organs in reproductive and gastrointestinal tracts and present a diagnosis in near real time. This approach is vastly superior to the present strategies of performing random biopsies. Thus, it can provide a powerful tool for screening large populations of patients for early precancerous changes. In its pilot clinical test in the esophagus at BIDMC this instrument, for the first time in the world, successfully guided biopsy detecting and mapping sites of invisible dysplasia missed by the current standard-of-care.

Studying Sub-Cellular Morphology with Confocal Light Absorption and Scattering Spectroscopic Microscopy

Confocal Light Absorption and Scattering Spectroscopic (CLASS) Microscopy developed at the Center is a novel way to use optical imaging techniques for non-invasive monitoring of embryonic cells on the submicron scale with no exogenous labels. The human embryo development and response to environmental factors could be monitored progressively at all critical stages using CLASS microscopy. For example, when cells are in metaphase, CLASS could provide information concerning the number and shape of chromosomes present. Since the CLASS measurement is nondestructive and requires no exogenous chemicals, a given embryo in vitro could be monitored over time before implantation. These kinds of progression studies are not possible with any other currently available techniques.

Optical Spectroscopic Technique for Noninvasive Prenatal Diagnosis

Non-invasive prenatal diagnosis utilizing fetal cells circulating in maternal peripheral blood has received much attention since it poses no risk to the fetus. Although several fetal cell types have been targeted, the search has focused on fetal nucleated red blood cells (fNRBC). Because of the low concentration of fNRBC in maternal blood, and interference by adult nucleated red blood cells (aNRBC), along with the failure to find broadly applicable identifiers that can differentiate fetal from aNRBC, reliable use of viable fNRBC in amounts sufficient for clinical use remains a challenge. We have demonstrated that fNRBC optical properties provide a unique optical biomarker that is based on the light scattering spectroscopic signatures of fNRBC and may enable isolation of these cells from maternal peripheral blood samples. This project can lead to development of a clinical minimally invasive prenatal genetic testing technique.

References:

Backman V, Wallace M, Perelman LT, et al. Detection of Preinvasive Cancer Cells. Early-Warning Changes in Precancerous Epithelial Cells Can Now be Spotted In Situ. Nature, 2000;406,6791:35-36.

Gurjar R, Backman V, Perelman LT, et al. Functional Imaging of Epithelial Tissues with Polarized Light Scattering Spectroscopy. Nature Medicine, 2001;7:1245-48.

Itzkan I, Qui L, Fang H, Zaman MM, Vitkin E, Ghiran IC, Salahuddin S, Modell MD, Andersson C, Kimerer LM, Cipolloni PB, Lim K-H, Bigio IJ, Itzkan I, Freedman SD, Sachs BP, Hanlon EB, & Perelman LT, Confocal Light Absorption & Scattering Spectroscopic (CLASS) Microscopy Monitors Organelles in Live Cells with no Exogenous Labels, Proc. Nat. Acad. Sci. USA, 2007; 104: 17255-17260.

Qiu L, Pleskow D, Chuttani R, Vitkin E, Leyden J, Ozden N, Itani S, Guo L, Sacks A, Goldsmith JD, Modell MD, Hanlon EB, Itzkan I, & Perelman LT. Multispectral Scanning during Endoscopy Guides Biopsy of Dysplasia in Barrett’s Esophagus, Nature Medicine, 2010; 16:603-606.

Vitkin E, Turzhitsky V, Qiu L, Guo L, Itzkan I, Hanlon EB, & Perelman LT. Photon diffusion near the point-of-entry in anisotropically scattering turbid media. Nature Commun. 2011; 2:587.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CA228029 (PERELMAN, LEV T) Sep 1, 2018 - Aug 31, 2024
    NIH
    Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression
    Role: Principal Investigator
  2. R01CA218382 (PERELMAN, LEV T) Feb 1, 2018 - Jan 31, 2024
    NIH
    Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument
    Role: Principal Investigator
  3. R01EB025173 (PERELMAN, LEV T) Sep 30, 2017 - Aug 31, 2022
    NIH
    Endoscopic Fine-Needle Polarized Scanning Spectroscopy for Pancreatic Cystic Lesions Diagnosis
    Role: Principal Investigator
  4. CBET-1605116 (PERELMAN, LEV T) Jul 1, 2016 - Jun 30, 2019
    NSF
    Early Non-Invasive Diagnosis of Liver Disease with Optical Spectroscopy
    Role: Principal Investigator
  5. R01CA205431 (PERELMAN, LEV T) May 16, 2016 - Apr 30, 2021
    NIH
    (PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Updating...
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Perelman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (144)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.